Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Edgewise Therapeutics Inc (EWTX)

212 + Investors. Track Smart Money conviction in EWTX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +15
Streak
2Q ▲
Buyers last Q
53%

Smart Money Signals — EWTX

Based on 214 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added EWTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
214 hedge funds hold EWTX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +11% more funds vs a year ago

fund count last 6Q
+21 new funds entered over the past year (+11% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 53% buying

111 buying98 selling
Last quarter: 111 funds bought or added vs 98 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~42 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 30 → 19 → 47 → 42. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

41% of holders stayed for 2+ years

■ 41% conviction (2yr+) ■ 31% medium ■ 29% new
87 out of 214 hedge funds have held EWTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Price up while funds trimmed (+23% value, -3% shares)

Value
+22%
Shares
-2%
Last quarter: total value of institutional EWTX holdings rose +23% even though funds reduced share count by 3%. The stock price increased enough to offset the selling. Institutions are quietly trimming into price strength — watch for rotation.
🚀

Acceleration phase — new buyers rushing in

33 → 30 → 19 → 47 → 42 new funds/Q
New funds entering each quarter: 30 → 19 → 47 → 42. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Deep conviction — 43% of holders stayed 2+ years

■ 43% veterans ■ 28% 1-2yr ■ 30% new
Of 223 current holders: 95 (43%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 21% AUM from major funds

21% from top-100 AUM funds
45 of 214 holders rank in the top 100 by AUM, accounting for 21% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.0
out of 10
Moderate Exit Risk
Exit risk score 4.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — EWTX

In 2026 Q1, 111 hedge funds were net buyers of EWTX (42 opened a new position, 69 added to an existing one), while 98 reduced or exited (71 trimmed, 27 sold completely) — a 53% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 21% of total institutional value in EWTX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +15 funds (more new holders than closures). Total institutional holders: 214.

Hedge Fund Ownership: EWTX

How many hedge funds hold EWTX — quarterly history vs. share price
Quarterly hedge fund ownership of EWTX vs. share price

Market Analysis: EWTX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: EWTX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Edgewise Therapeutics Inc (EWTX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much EWTX has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 74d ago
EWTX
+10.6%
XLV
+4.9%

EWTX outperformed XLV by +5.7% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 29d ago
EWTX
+5.3%
XLV
+6.0%

Since the filing became public, EWTX outperformed XLV by -0.7% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

22 top-rated funds 5 high-conviction
Consensus
5.9
/ 10
breadth
×
Elite
3.7
/ 10
conviction
Hedge Fund Positioning: EWTX
212 + Investors

Track Smart Money conviction in EWTX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 212 199 6.53%
13F Shares 119M 123M -2.89%
Total Value $3.74B $3.04B 22.79%
New Positions 40 47 -7
Increased Positions 66 69 -3
Closed Positions 27 21 +6
Reduced Positions 68 57 +11
Total Calls 8 9 -11.11%
Total Puts 4 5 -20.0%
PUT/CALL Ratio 0.5 0.56 Bullish

Statistics: EWTX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

212 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in EWTX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 EWTX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Novo Holdings A/S 13.65% 5,350,000 $168.5M
2 Orbimed Advisors LLC 9.69% 15,518,492 $488.8M
3 Cormorant Asset Management, LP 5.16% 3,260,000 $102.7M
4 Paradigm Biocapital Advisors LP 4.74% 7,365,038 $232.0M
5 Ally Bridge Group (NY) LLC 4.10% 161,000 $5.1M
6 MPM BioImpact LLC 4.04% 1,660,696 $52.3M
7 Squadron Capital Management LLC 4.04% 350,000 $11.0M
8 Siren, L.L.C. 3.87% 4,430,263 $139.6M
9 Ra Capital Management, L.P. 3.48% 10,428,437 $328.5M
10 KVP Capital Advisors, LP 3.13% 133,000 $4.2M
11 First Light Asset Management, LLC 2.83% 1,001,846 $31.6M
12 Perceptive Advisors LLC 2.73% 4,423,974 $139.4M
13 Braidwell LP 2.47% 2,347,583 $73.9M
14 Integral Health Asset Management, LLC 2.41% 1,600,000 $50.4M
15 Opaleye Management Inc. 2.07% 500,000 $15.8M
16 Soleus Capital Management, L.P. 1.85% 1,449,915 $45.7M
17 Stempoint Capital LP 1.78% 290,864 $9.2M
18 Lion Point Capital, LP 1.71% 9,100 $287K
19 Ishara Investments LP 1.47% 49,200 $1.5M
20 Sio Capital Management, LLC 1.22% 268,986 $8.5M
21 Baker BROS. Advisors LP 1.19% 6,575,940 $207.1M
22 Bellevue Group AG 1.15% 1,528,518 $48.1M
23 Diadema Partners LP 1.14% 212,500 $6.7M
24 Quantum Private Wealth, LLC 1.13% 116,624 $3.7M
25 Parkman Healthcare Partners LLC 1.05% 322,828 $10.2M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Edgewise Therapeutics Inc (EWTX)

What does the Smart Money Trend signal show for EWTX?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added EWTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for EWTX?

Slight buying edge — 53% buying: Last quarter: 111 funds bought or added vs 98 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for EWTX holders?

Strong quality — 21% AUM from major funds: 45 of 214 holders rank in the top 100 by AUM, accounting for 21% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held EWTX?

41% of holders stayed for 2+ years: 87 out of 214 hedge funds have held EWTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Edgewise Therapeutics Inc (EWTX) following the 2026 Q1 hedge fund 13F filings?

As of today, EWTX has moved +5.3% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -0.7%. Since the quarter end (March 31, 2026), EWTX has gained +10.6% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →